Five sub types of muscarinic receptors have been identified by pharmacological and molecular biological methods. The muscarinic receptor subtype mediating acid secretion at the level of the parietal cell was unknown. Therefore, this study was performed to characterize muscarinic receptors on rat gastric parietal cells using the 3 subtype-selective antagonists hexahydrosiladifenidol and silahexocyclium, which have high affinity for glandular M3 subtypes, and AF-DX 116, which has high affinity to cardiac M2 receptors. The affinity of these antagonists was determined by radio ligand binding experiments. In addition, their inhibitory potency on carbachol-stimulated inositol phosphate production was investigated. Inhibition of carbachol-stimulated aminopyrine uptake was used as an indirect measure of proton production. Hoth M3 antagonists, hexahydrosiladifenidol and silahexocyclium, had nanomolar affinities for parietal cell muscarinic receptors and potently antagonized inositol phosphate production with nanomolar Ki values. Silahexocyclium similarly antagonized aminopyrine accumulation while hexahydrosiladifenidol behaved as a noncompetitive antagonist. AF-DX 116 was a low-affinity ligand and a weak competitive antagonist at parietal-cell mus carinic receptors. It was concIuded that muscarinic M3 receptors mediate acid secretion probably by activation of the phosphoinositide second messenger system in rat gastric parietal cells. M uscarinic cholinergic receptors have originaIly been subclassified by their different affinities for the nonclassical muscarinic antagonist pirenzepine (1,2), which has high affinity for neuronal Ml and low affinity for non-Ml receptors. Based on molecular cloning of muscarinic receptors, there is now evidence for 5 different subclasses (3-5). Antagonists such as AF-DX 116 (6) were more potent in antagonizing muscarinic actions in cardiac M2 than in smooth muscle M3 (previously termed M2ß) receptors. Compounds such as hexahydrosiladifenidol (HHSiD) and silahexocyclium (SiHC] possess 10-30-fold higher affinity for smooth muscle and glandular M3 than cardiac M2-receptor subtypes (7, 8) .
Five sub types of muscarinic receptors have been identified by pharmacological and molecular biological methods. The muscarinic receptor subtype mediating acid secretion at the level of the parietal cell was unknown. Therefore, this study was performed to characterize muscarinic receptors on rat gastric parietal cells using the 3 subtype-selective antagonists hexahydrosiladifenidol and silahexocyclium, which have high affinity for glandular M3 subtypes, and AF-DX 116, which has high affinity to cardiac M2 receptors. The affinity of these antagonists was determined by radio ligand binding experiments. In addition, their inhibitory potency on carbachol-stimulated inositol phosphate production was investigated. Inhibition of carbachol-stimulated aminopyrine uptake was used as an indirect measure of proton production. Hoth M3 antagonists, hexahydrosiladifenidol and silahexocyclium, had nanomolar affinities for parietal cell muscarinic receptors and potently antagonized inositol phosphate production with nanomolar Ki values. Silahexocyclium similarly antagonized aminopyrine accumulation while hexahydrosiladifenidol behaved as a noncompetitive antagonist. AF-DX 116 was a low-affinity ligand and a weak competitive antagonist at parietal-cell mus carinic receptors. It was concIuded that muscarinic M3 receptors mediate acid secretion probably by activation of the phosphoinositide second messenger system in rat gastric parietal cells. M uscarinic cholinergic receptors have originaIly been subclassified by their different affinities for the nonclassical muscarinic antagonist pirenzepine (1,2), which has high affinity for neuronal Ml and low affinity for non-Ml receptors. Based on molecular cloning of muscarinic receptors, there is now evidence for 5 different subclasses (3) (4) (5) . Antagonists such as AF-DX 116 (6) were more potent in antagonizing muscarinic actions in cardiac M2 than in smooth muscle M3 (previously termed M2ß) receptors. Compounds such as hexahydrosiladifenidol (HHSiD) and silahexocyclium (SiHC] possess 10-30-fold higher affinity for smooth muscle and glandular M3 than cardiac M2-receptor subtypes (7, 8) .
We have previously analyzed the radioligand binding properties of muscarinic M2 receptors in homogenates of porcine gastric mucosa (9) . These data showed that HHSiD had high affinity (Kd = 3 nM) to the majority of mucosal receptors while AF-DX 116 had low affinity (Kd = 3000 nM) compatible with the M3 subtype. However, approximately 250/0 of the binding sites in mucosa had low affinity for HHSiD, suggesting the presence of a second subtype of muscarinic receptors. Muscarinic non-Ml receptors in enriched gastric parietal ceIls (10) activate the phosphoinositol system, which probably provides the second messengers activating acid secretion (10) (11) (12) (13) . This model system allows a characterization of the muscarinic receptor sub type iqvolved in acid secretion by both functional and radioligand binding studies (14, 15) . The aim of the present study was to characterize the muscarinic receptor subtype involved in the breakdown of phosphatidylinositols and proton production in isolated rat gastric parietal ceIls. To this end the inhibitory potencies of prototypic muscarinic M2 and M3 receptor-subtype-selective antagonists were determined in functionaI and radioligand binding studies.
Methods and Materials
Rat gastric mucosal cells were iso la ted anc! enriched to a parietal cell content of 720/0 ± 5% cell number as described (10) . Buffer of the following composition was used in all experiments: NaCI, 70 mM; KCl, 5 mM; sodium phosphate, 1.5 mM; HEPES, 50 mM; sodium bicarbonate, 20 mM; bovine serum albumin, 0.2%; pH, 7.4. Incubations were at 36°C in a Dubnoff shaker (Braun, Melsungen, West Germany) under an atmosphere of oxygen and carbon dioxide (95%:5%).
Radioligand Binding Experiments
Binding experiments were performed at a cell concentration of 2 million/mI per sampIe at 36°C using eH)-Nmethylscopolamine (NMS) as radioactive tracer (specific activity 71 and 85 Ci/mmol, NEN) as described previously (10) . Specific bin ding, obtained by subtracting bound radioactivity in the presence of 1 j,tM atropine, was 73% ± 4% (n = 9) of the total bound. Displacement curves were constructed by displacing 0.25 nM tritiated NMS with 11-13 concentrations of unlabeled ligands ( Figure 1 ). Data were analyzed with the program "Ligand" (16) . Receptor density was 8760 ± 610/ cell (n = 5).
Inositol Phosphate Determination
Cells were labeled with tritiated myoinositol, and the formation of inositol monophosphate was determined as described (10) in the presence of LiCI (10 mM) to obtain a measure of activation of phospholipase C (17) . (14) as described previously (10) . Aminopyrine accumulation is expressed as the ratio of intraglandular radioactivity to that in the supernatant (10, 14) . The mean aminopyrine ratio was 6.9 ± 1.3 (n = 9) for stimulation by 0.1 mM carbachol, 15 ± 4 for 0.1 mM dibutyryl cyclic adenosine mono phosphate (dB-cAMP), and 88 ± 19 for carbachol plus dB-cAMP (n = 5).
Arunlakshana-Schild Plots
Arunlakshana-Schild plots were calculated to determine antagonist affinities (18) by obtaining dose-response curves for carbachol (0.1 or 1 j,tM to 10 mM) for aminopyrine accumulation and inositol phosphate production in the absence and presence of 3 concentrations of antagonists: HHSiD, 50-500 nM; SiHC, 40-500 nM; AF-DX, 5-100 j,tM. Each experiment was independently performed 3-5 times in duplicates for each point, and mean values were used to ealculate Ki values.
Statistical Methods
Dose-response curves were analyzed with the "Allfit" program of DeLean et al. (19) , and the statisties implemented in the program were used to test for parallelism of the eurves (19) . Data are indieated as means ±SEM.
Materials
The soure es of chemieals and radioehemicals were as deseribed (9, 10) . Silahexoeyelium was synthesized as described by Taeke et al. (20) . 
Results
The interaction of the muscarinic antagonists HHSiD, SiHC, and AF-DX 116 with muscarinic receptors in enriched rat gastric parietal cells was studied by radioligand binding experiments. Analysis of the displacement curves against (3H)NMS indicated the presence of a single dass of bin ding sites with affinities of 6.2 ± 1.6 and 3.2 ± 0.6 nM for HHSiD and SiHC, respectively (Figure 1) . The M2 antagonist AF-DX 116 had a low affinity to the same single site of 3190 ± 635 nM (Figure 1) . Carbachol (0.1 mM) caused a 3.3 ± 0.4-fold (n = 6) stimulation of inositol phosphate formation. None of the antagonists significantly stimulated inositol phosphate production at doses of 0.1 nM-l0 JLM (n = 4), indicating a lack of partial agonistic activity. The stimulation of inositol phosphate production by carbachol was completely antagonized by HHSiD, SiHC, and AF-DX 116 with IC50 va lues of 58.2 ± 7.7 nM, 24.7 ± 3.5 nM, and 12.5 ± 2.6 JLM, respectively ( Figure  2 ). To characterize the type of inhibition and to determine antagonist affinities, an analysis according to Arunlakshana and Schild (18) yielded Ki values for HHSiD, SiHC, and AF-DX 116 of 5.1 nM, 1.5 nM, and 3.1 JLM, respectively ( Table 1 ). The accumulation of the weak base aminopyrine in the acidic intracellular tubulovesical compartment was used to obtain an indirect measure of hydrogen ion production by the isolated cells (14, 15) . The stimulation by 0.1 mM carbachol was inhibited half maximally by HHSiD at 67 ± 8.5 nM. However, doseresponse curves for carbachol in the presence of increasing concentrations of HHSiD showed a shift to the right and a flattening of the curves indicative of noncompetitive inhibition. Hexahydrosiladifenidol also inhibited aminopyrine accumulation stimulated by the cell-permeable cAMP analogue dB-cAMP with an IC50 of 443 ± 47 nM (n = 4). Because dB-cAMP acts intracellularly and thus through a receptorindependent pathway, HHSiD probably interfered with aminopyrine uptake by a receptor-independent mechanism.
Silahexocyclium and AF-DX 116 did not interfere with dB-cAMP-stimulated aminopyrine uptake and inhibited aminopyrine uptake stimulated by carbachol with IC50 values of 24 ± 3 nM and 15.7 ± 3.7 JLM, respectively. Increasing concentrations of SiHC and AF-DX 116 caused parallel right shifts of doseresponse curves for carbachol suggesting competitive inhibition. The Ki of SiHC and AF-DX 116 for inhibition of aminopyrine uptake determined by Schild analysis was 2.7 nM and 3.2 JLM (Table 1) .
Discussion
The present study attempts a classification of the muscarinic receptor sub type that mediates activation of phospholipase C and acid secretion. In the present study we. used 3 receptor-subtype-selective antagonists that had previously been shown to distinguish cardiac from smooth muscle or glandular muscarinic receptors.
The M3 antagonists, HHSiD and SiHC, had high affinity for muscarinic binding sites on isolated rat gastric parietal cells, while the affinity of the M2 antagonist, AF-DX 116, was low.
Antagonist potencies were also assessed in terms of functional parameters. Inositol phosphate is a metabolite of receptor-activated and phospholipase Cmedia ted breakdown of phosphatidyl inositols whieh is likely to represent a measure of muscarinie second messenger generation (17) . Hexahydrosiladifenidol and SiHC showed similarly high potencies, while AF-DX 116 had low potency, in antagonizing carbacholstimulated inositol phosphate production ( Figure 2 ). All substances behaved as competitive antagonists.
Hexahydrosiladifenidol and SiHC potently inhibited carbachol-stimulated aminopyrine accumulation, whieh was measured to obtain an estimate of acid secretion (14, 15) . In contrast, AF-DX 116 aga in was a weak antagonist. To exclude noncompetitive phenomena, we tested effects on receptor-independent, dBcAMP-stimulated aminopyrine uptake, whieh should not be affected by the antagonists. Although AF-DX 116 and the quarternary compound, SiHC, did not affect dB-cAMP-stimulated aminopyrine uptake, HHSiD exerted an inhibitory effect. In addition, HHSiD caused a flattening of dose-response curves for carbachol. Because HHSiD was a competitive antagonist of inositol phosphate production, the noncompetitive action is not related to the receptor interaction of the antagonist. The most likely mechanism may be a direct interference of the rather hydrophobie compound with aminopyrine uptake.
The Ki values calculated from the data on inositol phosphate production and aminopyrine uptake were in agreement with Kd values determined by radioligand binding experiments. This suggests that all 3 effects involved the same type of muscarinie receptor (Table 1; Figure 2 ). The pharmacologieal profile of this receptor corresponds to the glandular or M3 subtype of muscarinie receptors (1) (2) (3) (4) (5) (6) (7) (8) (9) . Therefore, the M3 subtype is likely to mediate muscarinic stimulation of acid secretion via activation of the inositol phosphate system at the parietal celllevel.
Baudiere et al. (13) recently determined the potency of HHSiD in isolated rabbit gastrie cells with regard to both receptor-binding affinity and inhibition of aminopyrine uptake. The affinity of HHSiD was <200 nM Kd in bin ding studies, and the Ki for inhibition of aminopyrine accumulation was 79 nM. The investigators did not indicate that noncompetitive phenomena were observed. The discrepancy compared with our study may relate to species-specific differences.
The primary structures of 5 different types of muscarinie receptors have been derived from the cloned nucleotide sequences, and their characteristies have been investigated after transfection into various cell types (3-5). The bin ding data obtained with AF-DX MUSCARINIC ACID SECRETION 221 116, HHSiD, and SiHC for the M3 receptor, which strongly activates phosphoinositide breakdown but does not inhibit adenylate cyclase (5), were similar to those observed in the present study. Thus, the subtype designated either m3 or mACh-III (3, 4) or HM4 (5) most likely corresponds to the M3 receptor present in rat parietal cells. Because this subtype is also present on submandibular and pancreatic cells, it may represent an important gastrointestinal and glandular muscarinie receptor. Isolated rat gastrie parietal cells should provide a well-defined system for the molecular, biochemieal, and functional characterization of this partieular muscarinic receptor subtype.
